Home › Pericardial Disorders › Maryland
Pericardial Disorders clinical trials in Maryland
3 studies for Pericardial Disorders are looking for participants at sites in Maryland.
Cities in Maryland
Transition to KPL-387 Monotherapy Dosing & Administration Study
- Investigational Site 025, Baltimore
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 30, 2026 · NCT07288216CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
- Johns Hopkins University, Baltimore
- MedStar Health Institute, Columbia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06708299Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387
- Investigational Site 043, Baltimore
RecruitingPhase 2/3
Ages 18 to 80 · All sexes · Updated Aug 26, 2026 · NCT07010159From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.